Treatment of Refractory Chronic Pruritus of Unknown Origin With Tofacitinib in Patients With Rheumatoid Arthritis.

Wang, Fang; Morris, Caroline; Bodet, Nancy D; Kim, Brian S

Wang, Fang; Morris, Caroline; Bodet, Nancy D; Kim, Brian S.

Affiliation

Wang F; Division of Dermatology, Department of Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri.
Morris C; Center for the Study of Itch, Washington University School of Medicine in St Louis, St Louis, Missouri.
Bodet ND; Division of Dermatology, Department of Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri.
Kim BS; Division of Dermatology, Department of Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri.

JAMA Dermatol ; 155(12): 1426-1428, 2019 12 01.

Article in En | MEDLINE | ID: mdl-31532472

Subject(s)

Arthritis, Rheumatoid/drug therapy; Piperidines/therapeutic use; Protein Kinase Inhibitors/therapeutic use; Pruritus/drug therapy; Pyrimidines/therapeutic use; Aged; Arthritis, Rheumatoid/complications; Chronic Disease/drug therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pruritus/complications; Pruritus/diagnosis; Severity of Illness Index; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Arthritis, Rheumatoid / Pruritus / Pyrimidines / Protein Kinase Inhibitors Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: JAMA Dermatol Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google